14 June 2016 EMA/274681/2016 Stakeholders and Communication Division

Agenda - EMA Human Scientific Committees' Working Party with Patients’ and Consumers’ Organisations (PCWP) meeting 14 June 2016, 09:00hrs to 13:00hrs – meeting room 3E

Co-Chairs: Isabelle Moulon (EMA) and David Haerry (PCWP) 14 June 2016

Action

08:45

Registration and reimbursement arrangements

08:55

Welcome and introduction / Health and safety information

Speaker

I. Moulon (EMA)

Disclosure of interests / Adoption of the agenda 1. PCWP activities 09:00

1.1 New PCWP mandate

For information

N. Bere (EMA)

09:10

1.2 PCWP members ‘Tour de table’

For information

All members

09:50

1.3 PCWP anniversary

For information

M. Mavris (EMA)

2. EMA initiatives to support and accelerate early access 10:00

11:15

2.1 Update on PRIME initiative

For information

J. Llinares Garcia (EMA)

2.2 Update on adaptive pathways

For information

F. Cerreta (EMA)

For information

A-S. Henry-Eude (EMA)

Coffee Break

3. Access to documents 11:30

3.1 Proactive publication of clinical study reports; redaction of commercially

and discussion

confidential information

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

14 June 2016

Action

Speaker

For information

Committee

4. Committees feedback 12:00

4.1 Feedback from scientific committee

representatives

members 5. EUPATI 12:30

5.1 EUPATI guidance documents

For information

D. Haerry

6. AOB 13:00

Lunch

Agenda - EMA Human Scientific Committees' Working Party with Patients’ and Consumers’ Organisations (PCWP) meeting EMA/274681/2016

Page 2/2

Agenda - European Medicines Agency - Europa EU

Jun 14, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom ... EMA initiatives to support and accelerate early access. 10:00 2.1 ...

76KB Sizes 4 Downloads 251 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Nov 3, 2016 - Scope: 'Optimising the development of ATMPs to meet patient needs' ... the CAT would like to discuss with company representatives in person.

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - under Article 107i of Directive 2001/83/EC, based on pharmacovigilance data. Action: For adoption of ..... manufacturing process; and 3) removal of the following missing information: special patient groups. Action: For .... analysis of

Agenda - European Medicines Agency - Europa EU
4 days ago - Meningococcal group A, C, W135 and Y conjugate vaccine - NIMENRIX (CAP) -. EMEA/H/C/002226/II/0078 . ...... Applicant: AstraZeneca AB.

Agenda - European Medicines Agency - Europa EU
Jul 31, 2017 - Human Medicines Research and Development Support Division. Agenda ... use of such prior knowledge in regulatory application dossiers, to support manufacturing and control strategies ... of accelerated access schemes.

Agenda - European Medicines Agency - Europa EU
Oct 26, 2016 - (as Web sites for social networking and microblogging) through which ... 09:10. Opening remarks. D. Haerry (PCWP)/. G. Calvo (HCPWP). 1.

Agenda - European Medicines Agency - Europa EU
Nov 27, 2017 - Some of the information contained in this agenda is considered commercially confidential or sensitive and therefore not disclosed. With regard to intended therapeutic indications or procedure scopes listed against products, it must be